ArticleInternational journal of cardiology. Heart & vasculature2026
Heterogeneity of estrogen and β-adrenergic receptors in female human coronary artery endothelial cells.
Article in International journal of cardiology. Heart & vasculature, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Editorial: Integrative endothelial signaling mechanisms in resistance arteries.Frontiers in physiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Estrogen protects vascular function, likely via adrenergic modulation. Previous studies of estrogen and beta-adrenoceptor (β-AR) interactions relied on non-coronary or animal models, limiting relevance to human coronary endothelium. This study aimed to characterize estrogen receptor (ER) and β-AR expression in human coronary artery endothelial cells (HCAECs), evaluate inter-donor variability, and determine whether ER stimulation alters β-AR gene expression. Methods: HCAECs from female donors were analyzed for expression of ERs (ERα, ERβ, GPER), and β-ARs (β Results: Immunofluorescence revealed presence of all three ERs and β-ARs in the HCAECs. ERα had the lowest mRNA expression, while GPER was the most abundant, with donor-dependent variability. ERβ and GPER proteins were slightly higher than ERα. β Conclusion: These findings demonstrate donor variability in ER and β-AR expression in HCAECs, limiting generalization. Under the tested conditions estrogen and ER agonists did not alter β-AR mRNA levels, suggesting that short-term ER stimulation is unlikely to regulate β-AR expression at the transcriptional level within this experimental setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.